MedTrace Logo

Effects of Sargassum Horneri Extract on Patients With Hypersensitivity

NCT03849378 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2022-04-26

No results posted yet for this study

Summary

The investigators conduct a randomized, double-blind, placebo-controlled study to investigate the effects of Sargassum Horneri Extract in patients with skin hypersensitivity for 12 weeks.

Conditions

  • Skin Hypersensitivity

Interventions

DIETARY_SUPPLEMENT

Sargassum Horneri Extract group

This group takes 1,000 mg/day of Sargassum Horneri Extract for 12 weeks.

DIETARY_SUPPLEMENT

Placebo group

This group takes 1,000 mg/day of Placebo Extract for 12 weeks.

Sponsors & Collaborators

  • Pusan National University Yangsan Hospital

    lead OTHER

Principal Investigators

  • Sang Yeoup Lee, MD · Pusan National University Yangsan Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
12 Years
Max Age
50 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-01-01
Primary Completion
2022-02-14
Completion
2022-02-28

Countries

  • South Korea

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03849378 on ClinicalTrials.gov